{"nct_id":"NCT00925015","title":"Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2009-06-17","start_date_type":"ACTUAL","primary_completion_date":"2010-07-28","primary_completion_date_type":"ACTUAL","completion_date":"2010-12-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}